HOME >> BIOLOGY >> NEWS
ICSI children are developing well at the age of eight

s, mongoloid eyes and overriding toes.

"We found no important medical problem in either of the two groups we studied. Weight, height, head circumference and Body Mass Index did not differ between the two groups. Ten per cent of ICSI children (15 out of 150) experienced a major congenital malformation compared to 3.3% (5 out of 147) of the spontaneously conceived (SC) children. Minor malformations were found in 24.1% (35 out of 145) ICSI children compared to 17.2% (25 out of 145) SC children."*

The researchers asked another research group in Western Australia to re-assess their data blindly, according to their own coding system. Their results reduced the percentage of major congenital malformations from 10% to 4% amongst the ICSI children, and from 3.3% to 0% amongst the SC children. Minor malformations were reduced from 24.1% to 4.8% in the ICSI children and from 17.2% to 4.8% in the SC children.

"Other results showed little, if any, difference between ICSI and SC children, physically or neurologically. ICSI children were not more likely to require additional therapy, to have had surgery or to be hospitalised. There was no greater medication intake or more chronic disease among the ICSI children," said Dr Belva.

"Overall, the findings from the clinical examinations at the age of eight are reassuring. There were no clinically important differences between ICSI and SC children. Major congenital malformations appeared to be more frequent in the ICSI group, even after the re-classification exercise; however, most were corrected by minor surgery.

"We should remember that malformations occur also in the 'normal' population and can be caused by genetic inheritance, the environment, disease or other causes. If one of the parents has a malformation, they could pass it on to their offspring. We do not think the ICSI technique itself is the cause of the malformations, but is more likely to be related to the parental genetic background an
'"/>

Contact: Emma Mason
wordmason@mac.com
44-771-129-6986
European Society for Human Reproduction and Embryology
19-Jun-2006


Page: 1 2 3

Related biology news :

1. Gene identified for Crohns disease in children
2. Gene discovered for type 1 diabetes in children
3. Key to tackling malaria may lie in bed nets for adults and older children
4. Cord blood may preserve insulin levels in children with type 1 diabetes
5. Researchers isolate new risk marker for overweight children
6. Study shows lizard moms dress their children for success
7. U of MN will lead national research study on causes of bone cancer in children
8. A few more minutes of maternal attachment may reduce anemia in children
9. 100 percent juice not associated with overweight in children
10. Lower IQ found in children of women who took epilepsy drug
11. Cat hair at home poses an allergy risk, particularly for young children

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/7/2019)... ... May 07, 2019 , ... ... Long Beach Convention and Entertainment Center from May 15- 17. At booth #226, ... solutions. These include flexible software, biometric hardware, mobile apps, specialized industry solutions, advanced ...
(Date:5/2/2019)... ... April 30, 2019 , ... Global ... announces today that Holotype HLA and other Omixon products will be featured in ... Immunogenetics (EFI) in Lisbon, Portugal. Among the major scientific events, Omixon’s ...
(Date:5/2/2019)... (PRWEB) , ... May 01, 2019 , ... ... Board of Directors has appointed John Rakow, the Company’s General Counsel, as Interim ... Richman and Zac Apte, are currently on administrative leave. There will also be ...
Breaking Biology News(10 mins):
(Date:4/9/2019)... ... ... The American Society of Gene & Cell Therapy (ASGCT) is excited to ... the presidential line of succession, at the 22nd Annual Meeting . Members of ... three-year term (2019-2021). , All five incoming members of the ASGCT Board of ...
(Date:4/8/2019)... , ... April 08, 2019 , ... US Capital ... a $15 million preferred equity investment in the privately held pharmaceutical company, S1 Biopharma ... drug, Lorexys, is targeted at female hypoactive sexual dysfunction disorder and is ready to ...
(Date:4/4/2019)... ... April 02, 2019 , ... Biomeme, Inc. , a ... latest field-ready solution for performing PCR, RT-PCR, qPCR, and Isothermal tests called ... Rosland Franklin, an English chemist and X-ray crystallographer who made significant contributions to ...
(Date:3/29/2019)... ... March 28, 2019 , ... Specific Diagnostics announced today ... with a second stage of funding for Specific’s Reveal™ rapid antibiotic susceptibility test ... of the $1.7 million already awarded by CARB-X. The additional $1.7M will enable ...
Breaking Biology Technology:
Cached News: